Colitis, Ulcerative
208
27
39
117
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
59 trials with published results (28%)
Research Maturity
117 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
11.1%
23 terminated out of 208 trials
83.6%
-2.9% vs benchmark
22%
45 trials in Phase 3/4
50%
59 of 117 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 117 completed trials
Clinical Trials (208)
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)
VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Confirmatory Clinical Study in Active Ulcerative Colitis
A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Long-term Extension Study of Ustekinumab in Pediatric Participants
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)